Published :
Tables : 62
Figures : 45
Category : Healthcare
No. of Pages : 220
Report Code : HC-U3311
Lung Cancer Surgery Market is predicted to value over USD 40 billion by 2027 end with a CAGR of over 6.5% during the forecast period 2020 to 2027. Rising prevalence of lung cancer, increasing geriatric population, soaring healthcare expenditure across the world are some of the factors responsible for the lung cancer surgery market growth. Furthermore, there has been a rise in the number of chronic obstructive pulmonary disease, who then are at a high risk of getting diagnosed with lung cancer. These factors shall bolster the growth of the market. The minimally invasive surgeries, robot-assisted surgeries and surgeries like cryo ablation radiofrequency ablation are some novel surgeries that are used for treating lung cancer. These novel processes provide different benefits like reduced hospital stay, less blood loss, smaller incision and shorter duration of chest tube. Therefore, these surgeries are preferred by both patients and surgeons. Furthermore, developing economies like Brazil and India have untapped potential for the lung cancer surgery market growth. With non-stringent regulations and lesser competition, the market in these countries is anticipated to proliferate during the forecast period. According to the World Bank estimates, the healthcare expenditure increased to over 5% of GDP in 2015. Such estimates shall boost the market growth. Market Segmentation: By Procedure • Thoracotomy • Lobectomy • Sleeve Resection • Segmentectomy • Pneumonectomy • Minimally Invasive Surgeries By Devices Surgical Instruments Hand Instruments Stapler Forceps Retractors Rib Shear Trocars Cutters Clamps Scissors Elevators Other Hand Instruments Monitoring and Visualizing Systems Cameras and Video Support Endoscopic Trocars with Optical View Endosurgical Equipment By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa The market is fragmented into procedure, devices and region. The procedure segment is categorised into thoracotomy, lobectomy, sleeve resection, segmentectomy, pneumonectomy, minimally invasive surgeries. The devices segment is diversified into surgical instruments, hand instruments, monitoring and visualising systems and endosurgical equipment. The surgical instruments segment is anticipated to hold the largest lung cancer surgery market share owing to the soaring rise in the number of patients requiring lung cancer surgeries. The thoracotomy segment is anticipated to lead the market owing to its minimal invasion, reduced hospital stays and technological advancements. Regional Analysis: The North America region is predicted to lead the market during the forecast period owing to advancements in the healthcare infrastructure, a strong presence of key market players in the region, increasing geriatric population, favourable reimbursement scenarios for lung cancer are some factors contributing to the growth of the market. Competitive Landscape: Some of the key market players are Ethicon US LLC, Intutive Surgical Inc., Olympus Corporation, Accuray Inc., AngioDynamics Inc., Teleflex Inc., KARL STORZ GmbH, Ackermann Instrumente GmbH, Scanlan International Inc., Trokamed GmbH. FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global lung cancer surgery market by devices, by procedures and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Rising prevalence of lung cancer, increasing geriatric population, soaring healthcare expenditure across the world are some of the factors responsible for the lung cancer surgery market growth. Furthermore, there has been a rise in the number of chronic obstructive pulmonary disease, who then are at a high risk of getting diagnosed with lung cancer. These factors shall bolster the growth of the market. The minimally invasive surgeries, robot-assisted surgeries and surgeries like cryo ablation radiofrequency ablation are some novel surgeries that are used for treating lung cancer. These novel processes provide different benefits like reduced hospital stay, less blood loss, smaller incision and shorter duration of chest tube. Therefore, these surgeries are preferred by both patients and surgeons. Furthermore, developing economies like Brazil and India have untapped potential for the lung cancer surgery market growth. With non-stringent regulations and lesser competition, the market in these countries is anticipated to proliferate during the forecast period. According to the World Bank estimates, the healthcare expenditure increased to over 5% of GDP in 2015. Such estimates shall boost the market growth.
Market Segmentation:
By Procedure • Thoracotomy • Lobectomy • Sleeve Resection • Segmentectomy • Pneumonectomy • Minimally Invasive Surgeries By Devices
By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
The market is fragmented into procedure, devices and region. The procedure segment is categorised into thoracotomy, lobectomy, sleeve resection, segmentectomy, pneumonectomy, minimally invasive surgeries. The devices segment is diversified into surgical instruments, hand instruments, monitoring and visualising systems and endosurgical equipment. The surgical instruments segment is anticipated to hold the largest lung cancer surgery market share owing to the soaring rise in the number of patients requiring lung cancer surgeries. The thoracotomy segment is anticipated to lead the market owing to its minimal invasion, reduced hospital stays and technological advancements.
Regional Analysis:
The North America region is predicted to lead the market during the forecast period owing to advancements in the healthcare infrastructure, a strong presence of key market players in the region, increasing geriatric population, favourable reimbursement scenarios for lung cancer are some factors contributing to the growth of the market.
Competitive Landscape:
Some of the key market players are Ethicon US LLC, Intutive Surgical Inc., Olympus Corporation, Accuray Inc., AngioDynamics Inc., Teleflex Inc., KARL STORZ GmbH, Ackermann Instrumente GmbH, Scanlan International Inc., Trokamed GmbH.
FutureWise Key Takeaways:
• Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global lung cancer surgery market by devices, by procedures and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Market Variables, Trends & Scope 4.1 Market Lineage Outlook 4.2 Penetration and Growth Prospect Mapping 4.3 Industry Value Chain Analysis 4.4 Cost Analysis Breakdown 4.5 Technology Overview 4.6 Regulatory Framework on Country Level 4.6.1 Reimbursement Framework 4.6.2 Standards and Compliances 5. Market Overview 5.1 Market Dynamics 5.1.1 Market Driver Analysis 5.1.2 Market Restraint Analysis 5.1.3 Industry Challenges 6. Market Analysis tools 6.1 Industry Analysis - Porter’s 6.1.1 Supplier Power 6.1.2 Buyer Power 6.1.3 Substitution Threat 6.1.4 Threat from new entrants 6.1.5 Competitive Rivalry 6.2 Pestel Analysis 6.2.1 Political Landscape 6.2.2 Environmental Landscape 6.2.3 Social landscape 6.2.4 Technology landscape 6.2.5 Legal Landscape 7. Lung Cancer Surgery Market, By Procedure Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 7.1 Thoracotomy 7.2 Lobectomy 7.3 Sleeve Resection 7.4 Segmentectomy 7.5 pneumonectomy 7.6 Minimally Invasive Surgeries 8. Lung Cancer Surgery Market, By Devices Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 8.1 Surgical Instruments 8.2 Hand Instruments 8.2.1. Stapler 8.2.2. Forceps 8.2.3. Retractors 8.2.4. Rib Shear 8.2.5. Trocars 8.2.6. Cutters 8.2.7. Clamps 8.2.8. Scissors 8.2.9. Elevators 8.2.10 Other Hand Instruments 8.3 Monitoring and Visualizing Systems 8.3.1. Cameras and Video Support 8.3.2. Endoscopic Trocars with Optical View 8.4 Endosurgical Equipment 9. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019 9.2.1. U.S. 9.2.2. Canada 9.2.3. Mexico 9.2.4 Rest of North America 9.3 Market Size (USD Mn) Forecast for North America 2020-2027 10. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Regional Market Trends 10.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 10.3.1. Brazil 10.3.2. Uruguay 10.3.3 Argentina 10.3.4. Rest of Latin America 10.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027 11. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5 Switzerland 11.2.6. Spain 11.2.7. Russia 11.2.8. Poland 11.2.9. Rest of Western Europe 11.3 Market Size (US$ Mn) Forecast for Europe 2020-2027 12. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1 Introduction 12.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 12.2.1 Japan 12.2.2 China 12.2.3 Singapore 12.2.4 Korea 12.2.5 India 12.2.6 Australia and New Zealand 12.2.7 ASEAN 12.2.8 Rest of Asia Pacific 12.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027 13. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1 Introduction 13.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 13.2.1 UAE 13.2.2 South Africa 13.2.3 Egypt 13.2.4 Saudi Arabia 13.2.5 Rest of MEA 13.3 Market Size (US$ Mn) Forecast for MEA 2020-2027 14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 14.1 Ethicon US LLC 14.1.1. Company Overview (HQ, Business Segments, Employee Strength) 14.1.2. Product Portfolio 14.1.3. SWOT Analysis 14.1.4. Financial Overview 14.1.5. Strategic Overview 14.2 Intutive Surgical Inc. 14.2.1. Company Overview (HQ, Business Segments, Employee Strength) 14.2.2. Product Portfolio 14.2.3. SWOT Analysis 14.2.4. Financial Overview 14.2.5. Strategic Overview 14.3 Olympus Corporation 14.3.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.2. Product Portfolio 14.3.3. SWOT Analysis 14.3.4. Financial Overview 14.3.5. Strategic Overview 14.4 Accuray Inc. 14.4.1. Company Overview (HQ, Business Segments, Employee Strength) 14.4.2. Product Portfolio 14.4.3. SWOT Analysis 14.4.4. Financial Overview 14.4.5. Strategic Overview 14.5 AngioDynamics Inc., 14.5.1. Company Overview (HQ, Business Segments, Employee Strength) 14.5.2. Product Portfolio 14.5.3. SWOT Analysis 14.5.4. Financial Overview 14.5.5. Strategic Overview 14.6 Teleflex Inc. 14.6.1. Company Overview (HQ, Business Segments, Employee Strength) 14.6.2. Product Portfolio 14.6.3. SWOT Analysis 14.6.4. Financial Overview 14.6.5. Strategic Overview 14.7 KARL STORZ GmbH 14.7.1. Company Overview (HQ, Business Segments, Employee Strength) 14.7.2. Product Portfolio 14.7.3. SWOT Analysis 14.7.4. Financial Overview 14.7.5. Strategic Overview 14.8 Ackermann Instrumente GmbH 14.8.1. Company Overview (HQ, Business Segments, Employee Strength) 14.8.2. Product Portfolio 14.8.3. SWOT Analysis 14.8.4. Financial Overview 14.8.5. Strategic Overview 14.9 Scanlan International Inc. 14.9.1. Company Overview (HQ, Business Segments, Employee Strength) 14.9.2. Product Portfolio 14.9.3. SWOT Analysis 14.9.4. Financial Overview 14.9.5. Strategic Overview 14.10 Trokamed GmbH. 14.10.1. Company Overview (HQ, Business Segments, Employee Strength) 14.10.2. Product Portfolio 14.10.3. SWOT Analysis 14.10.4. Financial Overview 14.10.5. Strategic Overview 15 Impact of COVID-19 15.1. Positive influence on the healthcare industry 15.2. The financial disruption of the manufacturing sector 15.3. Impact of COVID-19 on emerging companies 15.4. Significant mandates in the healthcare regulations initiated by administrations 15.5. The overall economic slowdown of the developing and developed nations 16. Competitive Intelligence and Competitive Matrix 16.1 Competitive Intelligence 16.2 Competitive Matrix 17. Major Deals and Strategic Alliances Analysis 17.1 Joint ventures 17.2 Mergers and acquisitions 17.3 Licensing and partnerships 17.4 Technology Collaborations 17.5 Strategic Divestments 17.6 Market Entry Strategies 18. Relevant Case Studies and Latest News Updates 19. Key Market Takeaway Points from the Market Analysts at Future Market Analytics
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics